Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control
Adam Wedrychowski, Holly Anne Martin, Yijia Li, Sushama Telwatte, Gayatri Nikhila Kadiyala, Meghan Melberg, Behzad Etemad, Elizabeth Connick, Jeffrey M. Jacobson, David M. Margolis, Daniel J. Skiest, Paul A. Volberding, Frederick Hecht, Steven G. Deeks, Joseph K. Wong, Jonathan Z. Li, Steven A. Yukl
Abstract
The findings presented here provide new insights into how HIV and cellular gene expression change after stopping ART in both noncontrollers and posttreatment controllers. Posttreatment control is associated with an early ability to limit increases in multiply-spliced HIV RNA, a delayed (and presumably immune-mediated) ability to reverse an initial rise in processive/completed HIV transcripts, and multiple differences in cellular gene expression pathways. These differences may represent correlates or mechanisms of posttreatment control and may provide insight into the development and/or monitoring of therapeutic strategies that are aimed at a functional HIV cure.